Difficulty: Medium
Average Score: 65%
Practice
Diazoxide is administered by slow IV injection in emergency treatment of hypertension because
Correct answer
D
Rationale
Diazoxide is a potent arterial vasodilator used in the emergency treatment of hypertension. The correct answer, option D, states that diazoxide is administered by slow IV injection because the drug is quickly inactivated by serum protein binding. This is crucial because if diazoxide is administered too quickly, it can lead to a rapid drop in blood pressure due to its fast inactivation, causing hypotension and potential adverse effects.
Option A is incorrect because diazoxide is not rapidly biotransformed by hepatic microsomal enzymes. Option B is also incorrect as the drug being highly lipid-soluble and deposited in fat does not relate to the need for slow IV administration. Option C is not relevant as hyperglycemia is not a primary concern when administering diazoxide for hypertension.
In an educational context, understanding the pharmacokinetics of cardiovascular drugs like diazoxide is crucial for healthcare professionals to ensure safe and effective administration. Knowing why a drug is administered in a specific manner can prevent adverse reactions and optimize patient outcomes. Slow IV administration of diazoxide is a key clinical consideration that aligns with its pharmacological properties to prevent sudden drops in blood pressure.
Option A is incorrect because diazoxide is not rapidly biotransformed by hepatic microsomal enzymes. Option B is also incorrect as the drug being highly lipid-soluble and deposited in fat does not relate to the need for slow IV administration. Option C is not relevant as hyperglycemia is not a primary concern when administering diazoxide for hypertension.
In an educational context, understanding the pharmacokinetics of cardiovascular drugs like diazoxide is crucial for healthcare professionals to ensure safe and effective administration. Knowing why a drug is administered in a specific manner can prevent adverse reactions and optimize patient outcomes. Slow IV administration of diazoxide is a key clinical consideration that aligns with its pharmacological properties to prevent sudden drops in blood pressure.